Cefdinir

头孢地尼

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameCefdinir
Drug Alias Name头孢迪尼CefdinirumCefzon Capsule全泽复Cefzon +[11] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics > Third-generation cephalosporins
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsUncomplicated skin and skin structure infectionsCommunity Acquired PneumoniaMastitis +[11] 
Global Approved IndicationsUncomplicated skin and skin structure infectionsCommunity Acquired PneumoniaOtitis Media +[10] 
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryJapan
Original Approved Date1991/12/01
Country/TerritoryPanamaUnited StatesCosta Rica +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesLtl Pharma Co LtdFujisawa Pharmaceutical Co Ltd
Inactive CompaniesAbbott LaboratoriesSandozBeijing University Of Chinese Medicine +[5] 
Active IndicationsGram-Positive Bacterial InfectionsGram-Negative Bacterial InfectionsBacterial Infections
Inactive IndicationsUncomplicated skin and skin structure infectionsCommunity Acquired PneumoniaMastitis +[8] 

Other Information

ATC CodeJ01DD15
Related LinksWikipediaDrugBankKEGG